Skip to content

Dental Expansion Guide

Buy or Build Your Second Dental Practice?

Acquisition buys a transition; de novo buys a ramp. Normalize the capital and clinical coverage, then compare earlier receipts with the cost of creating a new patient schedule.

Normalize

Purchase/project uses plus a separately funded cash reserve

Replace

Seller and owner labor with the coverage actually planned

Compare

Transition receipts versus construction and patient-ramp timing

Scope

An existing owner's second-site choice—not transaction instructions.

Should an established owner buy or build a second dental practice?

Buy when verified transition cash after replacement clinical coverage justifies the purchase and debt; build when location and operating control justify the funded ramp. In this hypothetical comparison, acquisition needs $800,000 of funding versus $600,000 for de novo, yet preserves much more first-year liquidity. De novo produces more mature monthly incremental cash but exhausts its $100,000 project reserve during the ramp. Neither the lower opening price nor the higher mature margin settles the choice.

This is a capital-allocation decision for someone who already owns a successful office. The first practice cannot keep all your chair time while you also replace a departing seller or personally launch a new schedule. Write the two-site coverage plan before accepting either seller earnings or a de novo projection.

Normalize what you are buying, follow the worked cash comparison, or complete the evidence checkpoint. For deal sequencing and diligence steps, the separate dental acquisition guide remains the transaction resource.

Compare complete opportunities, not unlike asking prices

The SBA acquisition-planning section identifies existing cash flow, contracts, leases and infrastructure as items to investigate, with accountant and attorney support. An existing customer base can simplify starting operations; it does not guarantee that the buyer will retain the cash flow.

Operating acquisitionDe novo office
Capital used before operationsPurchase price, diligence/closing, immediate equipment work, transition and deposits.Site costs, construction, equipment, hiring and launch; include delivery interfaces.
Cash after those usesFund payroll, payer timing, seller transition and unexpected attrition.Fund pre-opening carrying costs and the longer patient/collections ramp.
Clinician economicsReplace seller work at the actual planned schedule; price any temporary seller coverage.Price the owner/associate schedule before assuming rooms become collections.
Premises and equipmentConfirm transferable occupancy, useful equipment and required replacements.Confirm permitted use, delivery condition, buildable scope and installation.
Demand evidencePatient activity, provider mix, retention risk and post-close collection ownership.Distinct catchment, referral/inquiry evidence and demand acquisition cost.
What must be normalized before buying or building a second practice

ADA's buyer guidance specifically warns that a seller who owns the building and pays no rent can have financials that understate a buyer's future facility cost. The same logic applies to uncompensated seller work and deferred repairs. Add a real occupancy and replacement-labor assumption before calling reported earnings available cash.

Worked case: more expensive acquisition, stronger early cash

All inputs below are editorial hypotheticals, not practice valuations, market costs, wage benchmarks or lending quotes. Both alternatives use leased premises, preserve $100,000 of project cash after one-time uses, and use $150,000 of owner project capital. First-practice protected cash is excluded rather than silently available to cover either shortfall.

Acquire operating practiceBuild a new office
One-time uses$600,000 purchase + $30,000 diligence/closing + $40,000 immediate refresh + $30,000 transition/setup = $700,000.$240,000 build-out + $180,000 equipment + $80,000 site/hiring/other launch = $500,000.
Project funding$150,000 owner + $650,000 loan = $800,000.$150,000 owner + $450,000 loan = $600,000.
Cash remaining after uses$800,000 − $700,000 = $100,000.$600,000 − $500,000 = $100,000.
Monthly new debt service$8,233.93$5,700.41
Opening control dateMonth 1; refresh does not interrupt the modeled schedule.Month 4; months 1–3 carry costs only.
Hypothetical buy/build capital reconciliation with equal starting project cash

Both assumed loans are fixed at 9%, fully amortizing over 120 months, with payments from month 1. Payment = principal × 0.0075 ÷ [1 − 1.0075−120]. Funds and one-time uses occur at month zero, with no fees withheld. Immediate refresh and transition costs are included once above; recurring clinical compensation belongs below, not in an unsupported add-back.

The $100,000 is funded cash, not an expense or an extra sum to add to the funding total. Whether it is enough is an output of the dated cash forecast, not a reason to choose the same round number for a real project.

AcquisitionDe novo
Collected cash by month$80,000 in month 1; $90,000 in month 2; $100,000 in months 3–12.$0 in months 1–3; then $14k, $28k, $42k, $56k, $70k, $84k; $84k in months 10–12.
Variable cash cost25% of collections, excluding clinician compensation.Same 25% definition.
Open-month fixed cash cost$60,000: $24,000 fully loaded replacement clinician + $36,000 other staffing/occupancy/administration.$45,000: $18,000 fully loaded clinical coverage + $27,000 other fixed costs.
Pre-opening carrying costNone in this immediate-operation case.$10,000/month in months 1–3, replaced by $45,000 at opening.
First-site net contribution reduction$6,000/month from month 1.$8,000/month from month 4; no reduction before opening.
Coverage-normalized operating assumptions for the hypothetical second offices

Different coverage budgets are intentional: these opportunities have different schedules and service mixes. They are not an assertion that acquired clinicians cost more. In the actual comparison, reconcile provider hours, expected procedures and compensation line by line. Neither scenario assumes free seller labor or asks the same owner to work at both locations simultaneously.

Acquisition receipts are cash the buyer is entitled to receive after close; no seller-retained receivables are included. The early $80,000/$90,000 transition reflects assumed collection timing and retention, not a guarantee that historical patients follow a buyer. The de novo collections are receipts, not merely treatment produced during each month.

The first-year bridge and the mature result tell different stories

Incremental group cash = new-site collections × 75% − new-site fixed/carrying cost − new debt service − first-site contribution reduction. Existing first-site cash before the reduction and owner household draws are omitted from both alternatives to isolate the project effect. Use full unrounded payments for the results below.

AcquisitionDe novo
First-year collected cash$80k + $90k + 10 × $100k = $1,170,000.$14k + $28k + $42k + $56k + $70k + 4 × $84k = $546,000.
First-year incremental group cash$1,170,000 × 75% − 12 × $60,000 − 12 debt payments − 12 × $6,000 = −$13,307.10.$546,000 × 75% − 9 × $45,000 − 3 × $10,000 − 12 debt payments − 9 × $8,000 = −$165,904.92.
Cash low from $100k project start$79,032.15 at month 2.−$83,103.28 at month 8: funding gap, not an available overdraft.
End of year project-support cash$86,692.90−$65,904.92 absent additional funding.
Mature monthly incremental group cash$100,000 × 75% − $60,000 − $8,233.93 − $6,000 = $766.07.$84,000 × 75% − $45,000 − $5,700.41 − $8,000 = $4,299.59.
First-year versus mature cash in the worked acquisition/de novo comparison

The acquisition preserves $152,597.81 more first-year cash, but mature de novo adds $3,533.52 more per month under these assumptions. Dividing the first number by the second is not a proven crossover date: it assumes both mature paths persist and ignores later equipment, tax, debt balances, exit proceeds and uncertainty. It also fails to solve the de novo funding gap before month 8.

Acquisition has little recurring headroom. A 10% reduction from $100,000 to $90,000 costs $7,500 of monthly contribution, making mature incremental group cash −$6,733.93. The buyer should verify whether earlier receipts justify the price at replacement-labor economics, rather than paying for the seller's personal clinical earnings as if they were passive cash flow.

Earlier cash is valuable only when it is actually transferable

A full historical schedule can depend on the seller's procedures, personal relationships, staff and payer arrangements. Review transition duties and post-close receipt ownership before financing a presumed immediate cash stream. For de novo, an attractive site and completed construction are not evidence of a filled schedule.

An evidence checkpoint for both opportunities

The ADA transition diligence list includes active patients, provider hours, accounts receivable, collections, payer mix, staffing costs, equipment records and facility documents. Use these records to replace assumptions without treating a patient-chart count as a collection guarantee.

  1. Normalize clinical capacity. Show seller, owner and associate sessions, procedure compatibility, hygiene coverage and time away from office one. Record who replaces each departing role.
  2. Reconcile historical receipts. Match reported collections to bank and practice-system evidence; distinguish provider, payer, old receivables, adjustments and one-time items.
  3. Price immediate and deferred work. Include inspected equipment replacements, downtime, lease obligations and systems conversion in the appropriate capital or cash month.
  4. Confirm collection rights and dates. Have advisers address receivables ownership, payer arrangements and who funds transition payroll before receipts arrive.
  5. Stress both routes fairly. Combine acquisition attrition and staff replacement; combine de novo delay and weaker demand. Keep the original practice's protected cash outside available support unless a permitted transfer is an explicit decision.
  6. Choose on evidence, then fund. An attractive acquisition may be overpriced; a cheaper de novo may have an unaffordable cash low. Reject either opportunity if the evidence cannot support its obligations.

The ADA-hosted lender-authored second-location article contrasts an operating patient base with a from-scratch launch and highlights the owner-time burden. Its broad suggestion that acquisition is smoother is not proof that a particular deal is safer or worth more.

Use location analysis for the distinct demand each option reaches, and the full opening-budget guide for missing de novo uses. The working-capital worksheet turns collection dates into a funding need. Once the operating case works, compare relevant practice financing rather than letting the available loan determine the project.

Sources and calculation boundaries

Public ADA and SBA resources support diligence categories, not the hypothetical prices, staffing amounts, retention, interest rates or receipts. The cash schedule is pre-tax, includes full new loan payments, excludes owner draws and first-site baseline cash, and assigns the first-site reduction only from actual operation. No real-estate asset, investment recovery date, future capital replacement or residual practice value is modeled.

General planning information, not valuation, legal, accounting, clinical or investment advice. Obtain independent transaction review, actual operating evidence and a complete funded downside before committing.

Frequently asked questions

Buying can bring earlier receipts, an established schedule and a team, but only if those survive the transition and support replacement clinical labor and debt. Building gives more control over premises and systems but needs funded construction and patient-ramp time. Compare specific opportunities on a common calendar, not a purchase price against a construction quote.

Practice & firm funding

Compare funding for the opportunity you can operate

Bring normalized capital uses, clinical coverage and the dated transition or launch cash forecast.

  • A person reads this, not a bot, and replies within one business day.
  • This form authorizes neither a lender application nor a credit pull. Lender review needs separate permission. Preliminary illustrations are not final pricing; review final terms before signing.
  • We provide financing for your practice's next move. Review legal and tax questions with your own advisers before you sign.
  • We start with your plans, then explain the bank, SBA or nonbank financing that may fit. Costs and terms are clear before you commit; if another option is better, we say so.